Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Tannaz Armaghany"'
Autor:
Bambi Grilley, Monica Francois, Manik Kuvalekar, Juan Fernando Vera Valdes, Yvonne H. Sada, Brandon G. Smaglo, Carlos A. Ramos, Ann M. Leen, Adrian P. Gee, Ayumi Watanabe, Spyridoula Vasileiou, George Van Buren, Helen E. Heslop, Premal Lulla, LaQuisa Hill, William E. Fisher, Tao Wang, Benjamin L. Musher, Catherine Robertson, Tannaz Armaghany
Publikováno v:
Journal of Clinical Oncology. 38:4622-4622
4622 Background: Immunotherapy is emerging as a potent therapy for a range of hematologic malignancies and solid tumors. To target pancreatic carcinoma we have developed an autologous, non-engineered T cell therapy using T cell lines that simultaneou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f66dc96189d22c6a4de684a067e6f3af
https://doi.org/10.1200/jco.2020.38.15_suppl.4622
https://doi.org/10.1200/jco.2020.38.15_suppl.4622
Autor:
Jonathan R. Strosberg, David Smith, John D. Carpten, Mark Marion Kowalski, Winnie S. Liang, Sarabjit Gahir, Ramesh K. Ramanathan, Michael J. Demeure, Tannaz Armaghany, Paul Fredlund, Samuel Ejadi, Andrew Dye, Shobana Sekar, Sean C. Semple, Aymen Elfiky, Demi Niforos, Timothy G. Whitsett
Publikováno v:
Journal of Clinical Oncology. 34:2547-2547
2547Background: Polo-like kinase 1 (PLK1) regulates critical aspects of tumor progression. High expression levels correlate with poor survival in ACC. TKM-080301 is a lipid nanoparticle formulation of a siRNA against PLK1. Methods: TKM-080301 was eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2bddcdae5bee243070771ccdff45b43a
https://doi.org/10.1200/jco.2016.34.15_suppl.2547
https://doi.org/10.1200/jco.2016.34.15_suppl.2547
Autor:
Tannaz Armaghany, Katherine Root
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(25)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc9b32645f74c35319b2ce4f23239252
https://pubmed.ncbi.nlm.nih.gov/22753899
https://pubmed.ncbi.nlm.nih.gov/22753899
Autor:
Mohammad Hamidi, Gelareh Vahdati, Reza Amerinia, Tannaz Armaghany, Sanjay Thamake, Ebrahim S. Delpassand
Publikováno v:
Journal of Clinical Oncology. 33:e15175-e15175
e15175 Background: We retrospectively evaluated the efficacy of PRRT with 111 In-Octreotide (IN) or 117Lu-Octreotate (LU) in the treatment of high grade (HG) mNETS with a positive octreoscan image....
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9aeede17c4b5e51645b7ef2fba52fc1b
https://doi.org/10.1200/jco.2015.33.15_suppl.e15175
https://doi.org/10.1200/jco.2015.33.15_suppl.e15175
Autor:
Prakash Peddi, Lori Panu, Runhua Shi, Cherie-Ann O. Nathan, Syed Hasan Raza Jafri, Glenn Mills, F.L. Ampil, Tannaz Armaghany
Publikováno v:
Journal of Clinical Oncology. 30:e16009-e16009
e16009 Background: SCHNC is a common malignancy and approximately 60% of patients present with locally advanced disease. There is paucity of data directly comparing Cx and CDDP with concurrent radiation in locally advanced SCHNC. We retrospectively r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9bfd5eda00746f485ed0afefdfadb63
https://doi.org/10.1200/jco.2012.30.15_suppl.e16009
https://doi.org/10.1200/jco.2012.30.15_suppl.e16009
Publikováno v:
Journal of Clinical Oncology. 30:e14667-e14667
e14667 Background: Due to rarity, management of SBA is currently controversial. Despite results from several single institutional studies showing no survival benefit with adjuvant chemotherapy, data extrapolated from established colorectal cancer stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6bcd48ff704f1827f8ac8d4ca5c86c3b
https://doi.org/10.1200/jco.2012.30.15_suppl.e14667
https://doi.org/10.1200/jco.2012.30.15_suppl.e14667